Sign in to view content

Five-Year Outcomes After Initial Aflibercept, Bevacizumab, or Ranibizumab Treatment for Diabetic Macular Edema (Protocol T)

Dante Joseph Pieramici, MD

Video
Published 2020

Related

Episode 143: Journal Club, Pediatric Retinal Detachment Surgery, Open Label Extension RISE and RIDE, BP Changes during Injections
Jayanth Sridhar, MD
Member Podcasts
2018
Phase 2a Study of CU06-1004, an Oral Endothelial Dysfunction Blocker For the Treatment of Diabetic Macular Edema (DME)
Victor Hugo Gonzalez, MD
Annual Meeting Talks
2024
Relationships Between Total Retinal Volume and Visual and Anatomic Outcome Measures in Patients With Diabetic Macular Edema in RIDE and RISE
Michelle V. Carle, MD. MMEd
On Demand Cases, Courses, and Papers
2019

Category: Diabetic Retinopathy

See more